EUVIMEDEUVIMED entdecken
Open Access

Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308

Shaghayegh Nouruzi, Fraser Johnson, Sahil Kumar, Olena Sivak, Nakisa Tabrizian, Milla Koistinaho, Anu Muona, Amina Zoubeidi

Oncology Reports · 2024

DOI: 10.3892/or.2024.8791 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Shaghayegh Nouruzi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada. Hauptthemen laut MEDLINE: Phenylthiohydantoin, Nitriles, Benzamides, Drug Resistance, Neoplasm. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylthiohydantoinNitrilesBenzamidesDrug Resistance, NeoplasmCell ProliferationReceptors, AndrogenAdenocarcinomaAndrogen AntagonistsHumansMaleCell Line, TumorMiceAnimalsXenograft Model Antitumor AssaysProstatic NeoplasmsAndrogen Receptor Antagonists

Stichwörter der Autor:innen

ARPIsenzalutamide resistanceprostate cancer adenocarcinomatreatment- resistance

Substanzen

PhenylthiohydantoinNitrilesenzalutamideBenzamidesReceptors, AndrogenAndrogen AntagonistsAR protein, humanAndrogen Receptor Antagonists

Autor:innen und Institutionen

  • Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.
  • Aranda Pharma Ltd., 70210 Kuopio, Finland.

Zitieren

APA

Nouruzi, S., Johnson, F., Kumar, S., Sivak, O., Tabrizian, N., Koistinaho, M., Muona, A., & Zoubeidi, A. (2024). Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308. Oncology Reports. https://doi.org/10.3892/or.2024.8791

Vancouver

Nouruzi S, Johnson F, Kumar S, Sivak O, Tabrizian N, Koistinaho M, et al. Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308. Oncology Reports. 2024. doi:10.3892/or.2024.8791

BibTeX
@article{Nouruzi2024,
  author = {Nouruzi, Shaghayegh and Johnson, Fraser and Kumar, Sahil and Sivak, Olena and Tabrizian, Nakisa and Koistinaho, Milla and Muona, Anu and Zoubeidi, Amina},
  title = {Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308},
  journal = {Oncology Reports},
  year = {2024},
  doi = {10.3892/or.2024.8791}
}
Kostenlos starten →